언어선택 ENG
전체메뉴

News

Innovative Medicines based on
ImmunoModulatory Biologics

Signing a joint research agreement with Dong-A ST using ePENDY platform technology

  • Date
    2024-02-19 17:58:21
  • View
    1623

For more information, please visit : IMBiologics  News (full article available in Korean)

▲하경식 아이엠바이오로직스 대표(왼쪽), 박재홍 동아에스티 대표